[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367978-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-367978-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","non-invasive-identification-of-kras-mutation-in-rectal-cancer-using-hybrid-intravoxel-incoherent-motion-and-diffusion-kurtosis-imaging-ivim-dki-model","Non-invasive identification of KRAS mutation in rectal cancer using hybrid intravoxel incoherent motion and diffusion kurtosis imaging (IVIM-DKI) model","","KRAS mutation status serves as a crucial biomarker in rectal cancer because KRAS mutations are linked to resistance to anti-EGFR targeted therapies and can affect chemotherapy selection, prognosis, and treatment decisions. This study assesses the diagnostic performance of a hybrid intravoxel incoherent motion and diffusion kurtosis imaging (IVIM-DKI) model for non-invasive KRAS mutation identification. A prospective cohort of 73 patients underwent MRI with IVIM-DKI and KRAS status was verified by histopathology, with imaging parameters compared across mutation and wild-type groups and evaluated via ROC analysis.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/non-invasive-identification-of-kras-mutation-in-rectal-cancer-using-hybrid-intravoxel-incoherent-motion-and-diffusion-kurtosis-imaging-ivim-dki-model/367978/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/non-invasive-identification-of-kras-mutation-in-rectal-cancer-using-hybrid-intravoxel-incoherent-motion-and-diffusion-kurtosis-imaging-ivim-dki-model/367978.png","ImageObject",300,407,{"name":42,"@type":43},"kopisore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"Why is KRAS mutation status important in rectal cancer?","Question",{"text":63,"@type":64},"KRAS mutations act as key biomarkers because they are associated with resistance to anti-EGFR targeted therapies and can influence chemotherapy choice, prognosis, and treatment decisions.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was KRAS mutation status determined in the study?",{"text":68,"@type":64},"KRAS mutation status was determined by histopathological analysis after patients underwent MRI using an IVIM-DKI sequence.",{"name":70,"@type":61,"acceptedAnswer":71},"Which imaging parameter showed the best diagnostic performance?",{"text":72,"@type":64},"The diffusion kurtosis parameter (K) derived from the IVIM-DKI model showed the highest ROC performance, with AUC = 0.779, sensitivity 88.1%, and specificity 70.3%.",{"name":74,"@type":61,"acceptedAnswer":75},"What is the study’s main conclusion about the hybrid IVIM-DKI approach?",{"text":76,"@type":64},"The hybrid IVIM-DKI model, especially the diffusion kurtosis parameter, shows promise as a non-invasive imaging biomarker for identifying KRAS mutations in rectal cancer and may help support early detection of anti-EGFR therapy resistance.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},367978,1790195432,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":143,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":12,"update_tm":147,"read_time":148,"preview_page_count":33,"preview_urls":149},962090880963,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Yuan et al. World Journal of Surgical Oncology (2025) 23:442  \n[https://doi.org/10.1186/s12957-025-04097-2](https://doi.org/10.1186/s12957-025-04097-2)  \nWorld Journal of Surgical Oncology  \nRESEARCH Open Access  \nNon-invasive identification of KRAS mutation   in rectal cancer using hybrid intravoxelincoherent motion and diffusion kurtosis  \nmodel  \nJie Yuan 1†, Mingrong Yao 1†, Ziyuan Wang2*, WenliTan 1, Yun Zhang3, Huamei Yan4, Mengxiao Liu5, Kun Liu2, Hangjun Gong3* and Songhua Zhan 1*  \nAbstract  \nBackground and purpose Sarcoma Viral Oncogene Homologue (KRAS) mutation status is a crucial biomarker in rectal cancer as KRAS mutations confer resistance to anti-EGFR targeted therapies and influence chemotherapy selection, affecting treatment decisions and prognosis. This study evaluates the efficacy of the hybrid intravoxelincoherent motion and diffusion kurtosis imaging (IVIM-DKI) model for non-invasive KRAS mutation identification in rectal cancer.  \nMethods This prospective study included 73 patients with rectal cancer who underwent MRI scans using an IVIM-DKI sequence. KRAS mutation status was determined through histopathological analysis. The parameters derived from the hybrid IVIM-DKI model, including the apparent diffusion coefficient (ADC), true diffusion coefficient (D), diffusion kurtosis (K), perfusion fraction (f ), and pseudo-diffusion coefficient (D*), were compared between the KRAS mutation group and wild-type group. The diagnostic performance was evaluated using the receiver operating characteristic (ROC) curve. The hybrid IVIM-DKI parameters and their association with clinicopathological features were also explored.  \nResults Significant differences were observed between the KRAS mutation and wild-type groups for ADC, D, and K values (p \u003C 0. 05) . The K value derived from the IVIM-DKI model demonstrated the highest area under the ROC curve (AUC = 0 . 779) in characterizing KRAS mutation status, with a sensitivity of 88 . 1% and specificity of 70. 3% . The ADC  \n†Jie Yuan and Mingrong Yao contribute equally to this work and co-first authors.  \n*Correspondence: Ziyuan Wang [cjwzymerck@sina.com](cjwzymerck@sina.com)[ ](cjwzymerck@sina.com)Hangjun Gong [hangjung@126.com](hangjung@126.com)[ ](hangjung@126.com)Songhua Zhan[zhansonghua@sina.com](zhansonghua@sina.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nYuan et al. World Journal of Surgical Oncology (2025) 23:442 Page 2 of 10  \nvalue also showed moderate diagnostic performance (AUC = 0 . 702) . Specific IVIM-DKI parameters, such as f and K, were associated with various clinicopathological features, suggesting their potential as imaging biomarkers. Conclusion The hybrid IVIM-DKI model, particularly the diffusion kurtosis parameter, shows promise as a noninvasive imaging biomarker for KRAS mutation identification in rectal cancer. This approach may facilitate early dete","cbCaikT3KFUX2rN6","https://ap.wps.com/l/cbCaikT3KFUX2rN6","pdf",2602502,"English","# Abstract\n## Background and purpose\n## Methods\n## Results\n## Conclusion\n# Highlights\n# Keywords\n# Introduction","[{\"question\":\"Why is KRAS mutation status important in rectal cancer?\",\"answer\":\"KRAS mutations act as key biomarkers because they are associated with resistance to anti-EGFR targeted therapies and can influence chemotherapy choice, prognosis, and treatment decisions.\"},{\"question\":\"How was KRAS mutation status determined in the study?\",\"answer\":\"KRAS mutation status was determined by histopathological analysis after patients underwent MRI using an IVIM-DKI sequence.\"},{\"question\":\"Which imaging parameter showed the best diagnostic performance?\",\"answer\":\"The diffusion kurtosis parameter (K) derived from the IVIM-DKI model showed the highest ROC performance, with AUC = 0.779, sensitivity 88.1%, and specificity 70.3%.\"},{\"question\":\"What is the study’s main conclusion about the hybrid IVIM-DKI approach?\",\"answer\":\"The hybrid IVIM-DKI model, especially the diffusion kurtosis parameter, shows promise as a non-invasive imaging biomarker for identifying KRAS mutations in rectal cancer and may help support early detection of anti-EGFR therapy resistance.\"}]","Non-invasive identification of KRAS mutation in rectal cancer using hybrid intravoxel incoherent motion and diffusion kurtosis imaging (IVIM-DKI) model | PDF",1790174081,25,[150,154,158,162],{"page_no":22,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/75019f7cc2f3474819eca7c4cc70e4cb.webp",983,1310,{"page_no":26,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a19f6c6853829c9caace2b237250fc74.webp",982,1309,{"page_no":30,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/feebc1a62d0efa43568df651279ea008.webp",981,1308,{"page_no":33,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1c6c139c2ed1243e43be0011d576b61a.webp",980,1306]